STAAR Surgical Co
NASDAQ:STAA
Intrinsic Value
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. [ Read More ]
The intrinsic value of one STAA stock under the Base Case scenario is 21.88 USD. Compared to the current market price of 46.89 USD, STAAR Surgical Co is Overvalued by 53%.
Valuation Backtest
STAAR Surgical Co
Run backtest to discover the historical profit from buying and selling STAA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
STAAR Surgical Co
Current Assets | 365.3m |
Cash & Short-Term Investments | 220.7m |
Receivables | 98m |
Other Current Assets | 46.6m |
Non-Current Assets | 123.4m |
Long-Term Investments | 11.7m |
PP&E | 101.4m |
Intangibles | 1.8m |
Other Non-Current Assets | 8.5m |
Current Liabilities | 65m |
Accounts Payable | 13.6m |
Accrued Liabilities | 24.4m |
Other Current Liabilities | 27.1m |
Non-Current Liabilities | 37.7m |
Long-Term Debt | 42k |
Other Non-Current Liabilities | 37.7m |
Earnings Waterfall
STAAR Surgical Co
Revenue
|
322.4m
USD
|
Cost of Revenue
|
-69.8m
USD
|
Gross Profit
|
252.7m
USD
|
Operating Expenses
|
-224.6m
USD
|
Operating Income
|
28.1m
USD
|
Other Expenses
|
-6.8m
USD
|
Net Income
|
21.3m
USD
|
Free Cash Flow Analysis
STAAR Surgical Co
STAA Profitability Score
Profitability Due Diligence
STAAR Surgical Co's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
STAAR Surgical Co's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
STAA Solvency Score
Solvency Due Diligence
STAAR Surgical Co's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
STAAR Surgical Co's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
STAA Price Targets Summary
STAAR Surgical Co
According to Wall Street analysts, the average 1-year price target for STAA is 49.24 USD with a low forecast of 33.33 USD and a high forecast of 63 USD.
Ownership
STAA Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
STAA Price
STAAR Surgical Co
Average Annual Return | 27.46% |
Standard Deviation of Annual Returns | 76.09% |
Max Drawdown | -83% |
Market Capitalization | 2.3B USD |
Shares Outstanding | 48 865 900 |
Percentage of Shares Shorted | 22.31% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.
Contact
IPO
Employees
Officers
The intrinsic value of one STAA stock under the Base Case scenario is 21.88 USD.
Compared to the current market price of 46.89 USD, STAAR Surgical Co is Overvalued by 53%.